NeuroSense Therapeutics Ltd - Warrants (09/11/2026) Current Cash

The latest current cash for NRSNW is $170K as of December 2025. That compares with $3.4M in the prior-year period — down 95.1% year over year. Investors often review this figure alongside NeuroSense Therapeutics Ltd - Warrants (09/11/2026)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, NRSNW's current cash moved from $3.4M to $170K — a 95.1% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in NeuroSense Therapeutics Ltd - Warrants (09/11/2026)'s operating scale or balance-sheet position.

A current cash figure of $170K for NRSNW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting NRSNW's current cash ($170K), review year-over-year change from $3.4M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.